
Download App
>> | LShop | >> | Book | >> | Medicine | >> | Medical Study & Revi... | >> | Targeted Interferenc... |
ISBN
:
9783540312086
Publisher
:
Springer Berlin Heidelberg
Subject
:
Medical Study & Revision Guides & Reference Material
Binding
:
Hardcover
Year
:
2007
₹
14416.0
₹
10235.0
Buy Now
Shipping charges are applicable for books below Rs. 101.0
View Details(Imported Edition) Estimated Shipping Time : 15-18 Business Days
View DetailsDescription
Two aspects of biological research are major contributors to the progress in the understanding of cancer etiology and the development of new and improved cancer drugs. The sequencing of the human genome provides us with a basic overview of all our genes and gene products, and the insights into signaling pathways allow us to align crucial components of cellular regulation into an ordered functional context. A comparison of the genes in normal and in tumor cells shows that mutations in the DNA of a limited set of genes are responsible for the multiple stages of tumorigenesis and metastasis. Many of the affected genes, including oncogenes, tumor suppressor genes and genome stability genes, can be fitted into pathways. They encode molecules that stimulate tumor cell division or inhibit their death. Matching of therapeutic intervention with insights into the underlying molecular disease mechanism has already led to the development of drugs such as Herceptin and Glivec. The deregulation of pathways as a consequence of the altered biochemical function of mutated cancer genes provides the conceptual basis for future progress. Will it be possible to extrapolate this principle and derive more efficient drugs targeting cancer pathway components? Promising cell surface molecules, potential targets of monoclonal antibodies, and intracellular molecules with enzymatic activity, potential targets for low-molecular-weight synthetic inhibitors, have been identified. Our ability to predict the consequences of inhibition of such components, however, is still limited. For this reason, the development of targeted drugs remains a complex process, comprising rational and empirical elements. The state of development of tomorrow\'s cancer drugs, directed against growth factors, growth factor receptors and intracellular signaling molecules with kinase activities, is described in this book.
Related Items
-
of
Targeted Delivery of Small and Macromolecular Drugs
Ram I. Mahato
Starts At
16470.0
19152.0
14% OFF
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary Care 1st Edition. Edition
Starts At
22927.0
23883.0
4% OFF
Molecularly Targeted Therapy for Childhood Cancer 1st Edition. Edition
Starts At
22927.0
23883.0
4% OFF
Molecular Neurosurgery with Targeted Toxins illustrated edition Edition
Ronald G. Wiley
Starts At
18014.0
18765.0
4% OFF
Targeted Radionuclide Tumor Therapy: Biological Aspects 1st Edition
Starts At
20471.0
21324.0
4% OFF
Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
Starts At
13054.0
16117.0
19% OFF
Signal Transduction and Human Disease HRD Edition HRD Edition
Starts At
16799.0
19534.0
14% OFF
Practical Guide to Targeted Intraoperative Radiotherapy: Targit
Starts At
12282.0
12794.0
4% OFF
Neural Networks and Artificial Intelligence for Biomedical Engineering
Donna L. Hudson
Starts At
15918.0
18510.0
14% OFF
Are you sure you want to remove the item from your Bag?
Yes
No
Added to Your Wish List
OK
Your Shopping Bag
- 1 Item
Item
Delivery
Unit Price
Quantity
Sub Total
Order Summary